These analysis datasets can then be imported into WinNonlin or PKS. FDA expects to use these installed Pharsight tools to review clinical trial data, especially for clinical pharmacology and clinical ...
ST. LOUIS--(BUSINESS WIRE)--Pharsight, a market-leading provider of software and scientific services to improve productivity and decision-making in clinical drug development, today announced that it ...
ST. LOUIS--(BUSINESS WIRE)--Certara™, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, ...
An advanced and well-established residential course designed to: • Provide an interface between the computer analysis of PK and PD data and physiological concepts. • Equip delegates, through lecture ...
Pharsight has announced the launch of Phoenix NLME (Nonlinear Mixed Effects), the next generation of the company’s data processing and modelling software for population pharmacokinetic and ...